Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × tremelimumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Lung Cancer Metastatic 1 Liver Neoplasms 1 Hydronephrosis 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Follicular 1

Interventions

Carboplatin 5 Cisplatin 4 pembrolizumab 3 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Paclitaxel 2 Nivolumab 2 toripalimab 1 regorafenib 1 durvalumab 1 bavituximab 1 atezolizumab 1 aflibercept 1 Vitamin D 1 Tumor Burden 1 Tiragolumab 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiation 1 Quality of Life 1 Photochemotherapy 1 ON 01910 1 NEO212 1 Mohs Surgery 1 Lapatinib 1 Ipilimumab 1 IFL protocol 1 Histocompatibility Testing 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡